If market authorization in the US is your target, or if your drug’s indications require an additional pool of patients, MetaPharm Inc.’s dedicated US team will provide you with all the services you need. We are experts for European clients seeking to realize US projects.

MetaPharm Inc. has gathered many years of experience in clinical research with local CROs in the Canada, before the company in response to increasing requests by its clients, decided to establish its own Canada business. It is managed by a highly educated and committed local team with expertise in drugs, biologics, and devices (Class I-III).

For you as a Global client, the close cooperation of MetaPharm Inc. project management and operations teams in Europe and the US brings about a multitude of advantages: With your main contact person at MetaPharm Inc. being based in Canada, time difference is no longer an issue. Communication and collaboration are streamlined to meet different requirements and expectations. Standard operating procedures and working procedures are harmonized; the high MetaPharm Inc. standard of quality data is ensured at all times.

MetaPharm Inc.’s experts will accompany you through all stages of your product’s journey. Your clinical trial will benefit from our experience in developing regulatory strategies for the FDA, Health Canada and the EU, in addition to our expertise with NIH and DoD federal grants. What’s more, you will enjoy all the advantages of a larger international organization;

Our experienced local US team will give you regulatory support during pre-IND, IDE, de novo, and other formal meetings, as well as scientific advice with the FDA. Our experts will accompany your complete submission process in the US and Canada.